September 18, 2024 in HighField in the News BioSpace: Data from a Phase 1 Trial of HighField Biopharmaceuticals’ HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers PJWCreative 0 Like Post 0 Comment Click here Read More